Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0519 | 6.25301204819 | 0.83 | 0.9287 | 0.7921 | 1404673 | 0.8255829 | CS |
| 4 | -0.4181 | -32.1615384615 | 1.3 | 1.3 | 0.76 | 1549013 | 0.91272042 | CS |
| 12 | -0.048 | -5.16184535972 | 0.9299 | 1.55 | 0.76 | 1603723 | 1.15738408 | CS |
| 26 | -0.0181 | -2.01111111111 | 0.9 | 1.55 | 0.6617 | 1462083 | 1.01275263 | CS |
| 52 | 0.1315 | 17.5239872068 | 0.7504 | 1.55 | 0.4993 | 1553741 | 0.91718563 | CS |
| 156 | -7.0501 | -88.8817448311 | 7.932 | 15.195 | 0.4525 | 2125522 | 2.59513596 | CS |
| 260 | -12.1181 | -93.2161538462 | 13 | 16.79 | 0.4525 | 1518464 | 3.9249239 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
